Cajanine Reduces Anxiety and Fear Extinction Deficits in Female Mice

Clinicians managing post-traumatic stress disorder face significant challenges due to the limited efficacy of current pharmacological interventions and the complex, heterogeneous nature of the condition [1]. Emerging evidence suggests that chronic neuroinflammation and dysregulated ion homeostasis play critical roles in the progression of neuropsychiatric disorders and cellular apoptosis (programmed cell death) [2]. While the physiological underpinnings of stress-related pathology are increasingly understood, there remains a pressing need for therapies that can specifically modulate the inflammatory cascade within the central nervous system [1]. Furthermore, the distinct biological responses to trauma observed between sexes suggest that a one-size-fits-all approach to treatment may be insufficient [1]. A new study now offers fresh insights into a potential biochemical target that may address these persistent clinical gaps.